| Document Date: 2012-06-27 15:01:40
Open Document File Size: 1,59 MBShare Result on Facebook
City Cambridge / Santa Cruz Biotechnologies / / Company Qiagen / Treatment Group Dosage Level (mg/kg) Dosing / Sonic / Normal / Charles River Laboratories / Aventis / Birgit C. Schultes Momenta Pharmaceuticals / Caliper Life Sciences / Vector Laboratories / Eisai / Sanofi / BD Biosciences / Vector Labs / Momenta Pharmaceuticals Inc. / / Country United States / / IndustryTerm tissue processor / final product / cancer treatment / control / / MedicalCondition pancreatic adenocarcinoma / orthotopic human pancreatic ductal adenocarcinoma model / pancreatic tumor / tumor / Liver metastases / cancer / local metastasis / extensive fibrosis / tumors / metastasis / Molecular Cancer / human pancreatic adenocarcinoma cells / Primary and peritoneal tumors / fibrous tumor / peritoneal metastases / bioluminescent primary tumors / simultaneous pancreatic cancer / primary pancreatic tumor / BMC Cancer / tumor metastasis / inflammatory cells / Kidneys Bladder/tumor / pancreatic cancer / primary tumors / adenocarcinoma / primary tumor / / MedicalTreatment chemotherapy / / Person Jay Duffner / Neese Neese / Takashi K. Kishimoto / Van Noorden / Chia Lin Chu / Christopher M. Honan / William Avery / Alison Long / / Position RT / orthotopic mouse model / / Product Gemzar / SQ injections / Fragmin / Xa / / ProvinceOrState Massachusetts / / Technology alpha / antibodies / chemotherapy / Leica VIP200 tissue processor / /
SocialTag |
Abstract # 1524 M402, a novel heparan sulfate mimetic, inhibits pancreatic tumor growth and desmoplasia potentially via Shh signaling in an orthotopic mouse model Chia Lin Chu, Alison Long, Christopher M. Honan, Jay Du